O3-4-5Outpatient Chemotherapy for Patients With Unresectable or Metastatic Bone Sarcomas

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy374.046
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Therapeutic Efficacy and Dosage of Pazopanib for Metastatic or Unresectable Advanced Soft Tissue Sarcomas

Chemotherapy: Open Access
2014English

Combination Chemotherapy With Irinotecan and Cisplatin in Pretreated Patients With Unresectable or Recurrent Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2006English

First-Line Single-Agent Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer With Poor Performance Status

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

Imatinib for the Treatment of Patients With Unresectable and/or Metastatic Gastrointestinal Stromal Tumours: Systematic Review and Economic Evaluation

Health Technology Assessment
MedicineHealth Policy
2005English

Results of a Prospective Phase 2 Study of Pazopanib in Patients With Surgically Unresectable or Metastatic Chondrosarcoma

Cancer
Cancer ResearchOncology
2019English

5O_PRA Phase 1b/2 Study of Omaveloxolone in Combination With Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma

Annals of Oncology
MedicineOncologyHematology
2017English

Perioperative Chemotherapy With or Without Bevacizumab in Patients With Metastatic Colorectal Cancer Undergoing Liver Resection

Clinical Colorectal Cancer
OncologyGastroenterology
2013English

First-Line Chemotherapy vs Bowel Tumor Resection Plus Chemotherapy for Patients With Unresectable Synchronous Colorectal Hepatic Metastases

Archives of Surgery
2008English

SWOG 0514: A Phase II Study of Sorafenib in Patients With Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma

Investigational New Drugs
OncologyPharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy